Is the world at the start of a commodities supercycle?
Surging global demand has driven both copper and iron-ore prices to all-time highs.

Surging global demand for “appliances and electronic goods” during the pandemic has powered a boom in commodity prices, report Emily Gosden and Gurpreet Narwan in The Times. Copper and iron-ore prices have both hit all-time highs. The latter, used to produce steel, has more than doubled since early 2020, breaking through $200 a tonne for the first time ever. Brent crude oil is up by more than 30% so far this year.
A supercycle is a prolonged period of rising prices owing to structurally higher demand. The last one started after China’s accession to the World Trade Organisation in 2001 and lasted until the early 2010s.
Copper is white hot
Copper certainly looks to be heading for “a long bull market”, writes Andrew Bary in Barron’s. Decarbonisation means the world will need unprecedented amounts of copper wiring. An electric vehicle contains four times as much copper as an internal-combustion car.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Onshore wind turbines likewise need “four times as much copper” per megawatt generated compared with traditional power plants. On the supply side, the “constraints in copper are the worst they have ever been”, says Chris LaFemina of Jefferies. Relatively little new supply is being added and it can take six to eight years to get a new mine up and running.
There are some signs of excess emerging, says Matt Egan for CNN Business. US steel prices have tripled this year to hit a record high: many mills stopped running last year, creating a “huge shortage”. Yet with the prospects for demand for steel unclear, some analysts think things will “end in tears”.
Not all industrial metals are “glowing white hot”, says Andy Home for Reuters. Zinc is up by 9% so far this year; lead 10%. That makes them comparative laggards: copper has more than doubled since its Covid-19 lows last year. Neither zinc nor lead is likely to benefit from the push to go green. Indeed, lead’s exposure to the car market could see it lose out. The two metals are likely to be left behind again, just as they were during the last supercycle.
The jury is still out on whether the commodity bump is the start of a supercycle or just post-pandemic normalisation, says Tom Stevenson in The Daily Telegraph. Fully fledged supercycles are rare: there have been just four in the last 150 years. But when one gets going it can “last for years”. The “green metals” (copper, nickel, aluminium, platinum) certainly have a good shot. Governments are encouraging green energy. One-third of Joe Biden’s “Jobs Plan” will be spent on “transport infrastructure” and electric vehicles. Raw-materials stocks tend to pay handsome dividends that compound over time. A prolonged boom could “make a generation of investors rich”.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Tesco braces for supermarket price war with rival Asda
Tesco, Britain’s biggest grocer, has opted to cut its prices more quickly to prevent Asda grabbing market share
By Dr Matthew Partridge
-
Supersonic travel: How China could 'leapfrog' US and Europe's commercial aviation industry
Opinion Innovation in commercial aviation has been stuck for 60 years. A commercial supersonic jet might be back on the market soon, but will China get there first?
By Matthew Lynn
-
BP's 'long, painful decline' – and why next year could be even tougher
Opinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
By Matthew Lynn
-
Investment trusts tap the profits in exotic and obscure global markets
Opinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money
By Peter Walls
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves